Company Description
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States.
It operates through Nutraceuticals and Pharmaceuticals segments. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.
It is involved in the research, development, manufacturing, marketing, and sale of science based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods, as well as manufacturing, marketing, and sale of science-based health and cosmeceutical solutions.
The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine.
The company is based in Vancouver, Canada.
| Country | Canada |
| Founded | 2007 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 2 |
| CEO | Ilan Sobel |
Contact Details
Address: 1140-625 Howe Street Vancouver, BC V6C 2T6 Canada | |
| Phone | 604 689 5722 |
| Website | bioharvest.com |
Stock Details
| Ticker Symbol | BHST |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001723464 |
| ISIN Number | CA09076J2074 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ilan Sobel | Chief Executive Officer |
| Dr. Zaki Rakib Ph.D. | Co-Founder, Executive Chairman and President |
| Dr. Yoheved Hagay Ph.D. | Co-Founder, Chief Technology Officer and Member of Scientific Advisory Board |
| Dr. Ilana Belzer Ph.D. | Chief Operating Officer |
| David K. Ryan | Vice President of Investor Relations and Secretary |
| Bar Dichter | Chief Financial Officer |
| Dr. Malkit Azachi Ph.D. | Vice President of Research and Development |
| Michal Abargel Sapir | Vice President of Regulatory Affairs |
| Jared Turner | Vice President of D2C Products Business Unit |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 24, 2025 | 424B7 | Filing |
| Sep 23, 2025 | 6-K | Report of foreign issuer |
| Sep 22, 2025 | 6-K | Report of foreign issuer |
| Sep 10, 2025 | 6-K | Report of foreign issuer |
| Sep 9, 2025 | 6-K | Report of foreign issuer |
| Sep 9, 2025 | 6-K | Report of foreign issuer |
| Sep 8, 2025 | EFFECT | Notice of Effectiveness |
| Sep 2, 2025 | 6-K | Report of foreign issuer |
| Aug 28, 2025 | DEL AM | Filing |
| Aug 28, 2025 | F-3 | Filing |